News

The upcoming oral data will test whether this level of efficacy and tolerability can be achieved in a more convenient, patient-friendly form.
HUTCHMED (China) Limited announced that it will present new and updated clinical data from its studies at the 2025 World Conference on Lung Cancer and the CSCO Annual Meeting. The presentations will ...
The US Food and Drug Administration (FDA) has created a new pathway to streamline rare disease drugs through regulatory ...